AB 265
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Sponsors1 cosponsor more
Jim WoodCalifornia lawmaker · DAB 265
Prescription drugs: prohibition on price discount
California · Became law
Lobbied on it8 of 58
Astrazeneca Pharmaceuticals, LP5 reportsKaleo4 reportsMerck, Sharp & Dohme LLC4 reportsAmerican Lung Association Dba American Lung Association in California3 reportsAstellas Pharma US, Inc.3 reportsBayer U.S. LLC3 reportsBiocom California3 reportsBoehringer Ingelheim Pharmaceuticals, Inc.3 reportsEvery link on this map
The same connections as a table, with the reason each one is here.
| Jim Wood | Sponsors | Jim Wood sponsored AB 265. | None |
| Astrazeneca Pharmaceuticals, LP | Lobbied on it | Astrazeneca Pharmaceuticals, LP named AB 265 in 5 lobbying reports. | 5 reports |
| Kaleo | Lobbied on it | Kaleo named AB 265 in 4 lobbying reports. | 4 reports |
| Merck, Sharp & Dohme LLC | Lobbied on it | Merck, Sharp & Dohme LLC named AB 265 in 4 lobbying reports. | 4 reports |
| American Lung Association Dba American Lung Association in California | Lobbied on it | American Lung Association Dba American Lung Association in California named AB 265 in 3 lobbying reports. | 3 reports |
| Astellas Pharma US, Inc. | Lobbied on it | Astellas Pharma US, Inc. named AB 265 in 3 lobbying reports. | 3 reports |
| Bayer U.S. LLC | Lobbied on it | Bayer U.S. LLC named AB 265 in 3 lobbying reports. | 3 reports |
| Biocom California | Lobbied on it | Biocom California named AB 265 in 3 lobbying reports. | 3 reports |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Lobbied on it | Boehringer Ingelheim Pharmaceuticals, Inc. named AB 265 in 3 lobbying reports. | 3 reports |